Avalo Therapeutics, Inc. (AVTX) vs Prime Medicine, Inc. (PRME)
- Avalo Therapeutics, Inc. AVTX 11.27 −6.16%
- Prime Medicine, Inc. PRME 3.47 −3.88%
Avalo Therapeutics, Inc. and Prime Medicine, Inc. are both Biotechnology companies. Avalo Therapeutics, Inc. and Prime Medicine, Inc. are of similar size ($654.8M and $644.1M). Prime Medicine, Inc. grew revenue faster over the last twelve months: −17.9% against −92.7%. Avalo Therapeutics, Inc. has the higher net margin (0.00% vs −4,613.1%) and the lower return on invested capital (−118.2% vs 0.00%). Across the 16 metrics below, Avalo Therapeutics, Inc. leads on 8 and Prime Medicine, Inc. on 8.
Valuation
Profitability
| Metric | AVTX | PRME | Biotechnology median |
|---|---|---|---|
| Gross margin | 64.72% | 100.00% | 65.16% |
| Operating margin | 0.00% | (4,824.94%) | 0.00% |
| Net margin | 0.00% | (4,613.11%) | 0.00% |
| Free cash flow margin | 0.00% | (3,850.92%) | 0.00% |
| Return on equity | (36.27%) | (373.29%) | (56.36%) |
| Return on assets | (32.50%) | (71.16%) | (48.04%) |
| Return on invested capital | (118.21%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack